In acute lymphoblastic leukemia, enhancement of MPT by resveratrol, an F-ATP synthase inhibitor, and CsA, an inhibitor of CypD, were shown to enhance cell death in both p53-mutant and wild-type cancer cells [222]. The gene discussed is TP53; the disease is cancer.